Add to ORKGThis invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) using the leading flavone compound acacetin, and its derivatives and analogues that inhibit the ultra-rapidly-activating delayed rectifier potassium current (IKur or IKsus), transient outward potassium (Ito), and acetylcholine-activated potassium current (IK.ACh).published_or_final_versio
Water-soluble derivatives and/or prodrugs of acacetin are described herein. The compounds can be use...
In the wake of demographic change in Western countries atrial fibrillation has reached an epidemiolo...
BackgroundJ wave syndromes (JWS), including Brugada (BrS) and early repolarization syndromes (ERS), ...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This journal issue is proceedings of ICSM 2010Abstracts for Oral CommunicationsWe have recently demo...
BACKGROUND - The development of atrium-selective antiarrhythmic agents is a current strategy for inh...
Oral Presentations: S23 Session - Molecular Cardiology, Basic Research: abstract O93We have recentl...
Poster presentationBackground and objective: We have recently demonstrated that the natural flavone ...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
The natural flavones and polymethylflavone have been reported to have cardiovascular protective effe...
Water-soluble derivatives and/or prodrugs of acacetin are described herein. The compounds can be use...
In the wake of demographic change in Western countries atrial fibrillation has reached an epidemiolo...
BackgroundJ wave syndromes (JWS), including Brugada (BrS) and early repolarization syndromes (ERS), ...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This invention provides a method for treating or preventing human atrial arrhythmia (fibrillation) u...
This journal issue is proceedings of ICSM 2010Abstracts for Oral CommunicationsWe have recently demo...
BACKGROUND - The development of atrium-selective antiarrhythmic agents is a current strategy for inh...
Oral Presentations: S23 Session - Molecular Cardiology, Basic Research: abstract O93We have recentl...
Poster presentationBackground and objective: We have recently demonstrated that the natural flavone ...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
The natural flavone acacetin has been demonstrated to inhibit transient outward potassium current (I...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
Atrial fibrillation (AF) is the most common cardiac arrhythmia. Developing effective and safe anti-A...
The natural flavones and polymethylflavone have been reported to have cardiovascular protective effe...
Water-soluble derivatives and/or prodrugs of acacetin are described herein. The compounds can be use...
In the wake of demographic change in Western countries atrial fibrillation has reached an epidemiolo...
BackgroundJ wave syndromes (JWS), including Brugada (BrS) and early repolarization syndromes (ERS), ...